Current Report Filing (8-k)

Date : 12/04/2018 @ 11:08AM
Source : Edgar (US Regulatory)
Stock : Genethera, Inc. (PN) (GTHR)
Quote : 0.0027  0.0 (0.00%) @ 10:00PM

Current Report Filing (8-k)

 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
 
Date of Report (Date of earliest event reported): November 30, 2018
 
GENETHERA, INC.

(Exact name of registrant as specified in its charter)
 
Nevada
000-27237
65-0622463
(State or other jurisdiction
of incorporation)
(Commission
File Number)
(I.R.S. Employer
Identification No.)
 
 6860 Broadway, Denver, CO
80221
(Address of principal executive offices)
(Zip Code)
 
Registrant’s telephone number, including area code:   (303) 955-0190
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy t he filing obligation of the registrant under any of the following provisions.
  
☐     Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
  
☐     Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
  
☐     Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act ( 17 CFR 240.14d-2(b))
  
☐     Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
 
1
 
 
Item 1.01 Entry into a Material Definitive Agreement.
 
GENETHERA INC. COMPLETES THIRD MILESTONE OF THEIR “MILESTONE INVESTMENT AGREEMENT” WITH FOGT, LLC
 
On November 30 th 2018, GeneThera Inc. completed the third milestone as described in Exhibit A of the Milestone Investment Agreement. The Completion of this milestone enables the Company to receive a payment of $1,200,000 under the Terms of the Agreement.
 
 
Item 9.01 Financial Statements and Exhibits.
 
 

 
 
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Current Report on Form 8-K to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
 
GeneThera, Inc.,
a Nevada Corporation  
 
 
 
 
 
 
By:  
/s/ Antonio Milici
 
 
 
Antonio Milici, CEO
 
Date: December 4, 2018
 
 
 
 
 
 
2

GeneThera, Inc. (OTCBB:GTHR)
Historical Stock Chart

1 Year : From Jul 2018 to Jul 2019

Click Here for more GeneThera, Inc. Charts.

GeneThera, Inc. (OTCBB:GTHR)
Intraday Stock Chart

Today : Tuesday 16 July 2019

Click Here for more GeneThera, Inc. Charts.

Latest GTHR Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.